MediSensonic SA
launched a public offering
of 10 to 200,000 series H
ordinary bearer shares.

Important informations:

Before accessing the information provided on this website, please read carefully the following terms and conditions for accessing this website and the important information provided on it. By selecting the “Accept and Continue” option below, you acknowledge that you have read the following important information, agree to the restrictions contained therein, and undertake to abide by these restrictions. Please note that the important information presented below may be subject to change or update. Accordingly, you should read and review them in their entirety each time you visit this website.

The materials and information to which you will gain access relate to or are related to the public offering of 10 to 200 000 series H ordinary bearer shares of MediSensonic S.A. with its registered office in Wroclaw, Poland (the “Company”, the “Issuer”) conducted on the territory of the Republic of Poland (the “Public Offering”). The terms and conditions of the Public Offering are set forth in the Information Memorandum for the Public Offering (the “Information Memorandum”) published on the Company’s website at https://www.medisensonic.com/ and on DM INC’s website at https://platforma.dminc.pl.

The Company is responsible for the truthfulness, accuracy and completeness of all information contained in the Information Memorandum. Subject to the provisions of law, the intermediary in the Public Offering, i.e., DM INC S.A. (“DM INC”), or any affiliate of DM INC, is not responsible for the truthfulness, accuracy and completeness of the information disclosed in the Information Memorandum, supplements and update communications thereto, except for the information indicated in the content of DM INC’s statement contained in Chapter III of the Information Memorandum.

The Information Memorandum is the only legally binding document containing, for the purposes of the Public Offering, information about the Company, the offered shares of the Company and the Public Offering. The Information Memorandum has not been subject to approval or review by the Financial Supervision Commission. You should read the Information Memorandum and any supplements and update communications to it before making an investment decision to subscribe for the Company’s shares in the Public Offering.

An investment in shares involves a number of investment risks, and investors should therefore carefully and thoroughly read the entire Information Memorandum, in particular the risks described therein related to investing in the Company’s shares. The materials on this website include the Information Memorandum, any supplements and update communications thereto, and information that is of a promotional nature (advertising) and is either used for the purposes of the Public Offering or constitutes information provided by the entity conducting the Public Offering to the public in fulfillment of its obligations.

These materials and information do not constitute an offer to sell securities in the United States, Canada, Japan, Australia or any other jurisdiction where to do so would constitute a violation of applicable law or require registration, filing or authorization. The securities may not be offered or sold in the United States of America unless they have been registered with the U.S. Securities and Exchange Commission or are exempt from registration under the relevant provisions of the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The Company’s securities have not been and will not be registered under the provisions of the U.S. Securities Act and may not be offered or sold in the United States except pursuant to an exemption from registration or in transactions not subject to the registration requirements of the U.S. Securities Act. Neither the Information Memorandum nor the shares of the Company subject to the Public Offering covered by it have been and will not be subject to registration, approval or notification in any country outside the Republic of Poland, in particular in accordance with the regulations of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017. on the prospectus to be published in connection with a public offering of securities or their admission to trading on a regulated market and repealing Directive 2003/71/EC, and may not be offered or sold outside the Republic of Poland (including in other countries of the European Union, the United States of America, Canada, Japan and Australia), unless in the relevant country such an offer or sale could be made in accordance with the law, without any additional legal requirements to be met by the entity conducting the Public Offering and its advisors in connection with the Public Offering. Any investor residing or having its registered office outside the Republic of Poland should familiarize itself with the relevant provisions of Polish law and the regulations of other countries that may apply to it in connection with participation in the Public Offering.

The Public Offering is not directed to Russian or Belarusian citizens or natural persons residing in Russia or Belarus, or to any legal entities or other organizational units established in Russia or Belarus, or other entities subject to offering restrictions under national and EU laws.

Back to main website